US 8618106
Protein kinase inhibitors
granted A61PA61P1/04A61P1/16
Quick answer
US patent 8618106 (Protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/00